Neonatal Medicine

The Korean Society of Neonatology (대한신생아학회)
권호 표지
DOI QR코드

DOI QR Code

Disorders in Hemostasis

  • Sung, Tae-Jung (Department of Pediatrics, College of Medicine, Hallym University)
  • Published : 2011.05.31
⟨ Previous Next ⟩

Abstract

Neonatal bleeding is a common problem encountered in nursery rooms or neonatal intensive care units, especially among premature infants. Furthermore, owing to recent remarkable improvement of neonatology, survival rates of preterm neonates have increased; hence, neonatal bleeding cannot be emphasized enough. Since the total blood volume of neonates is small, bleeding can be one of the causes of morbidities and mortalities. Therefore, rapid diagnosis and immediate therapy is urgently needed. The patient's medical history including a familial history of a bleeding disorder or of a previously affected infant who suffered from bleeding along with maternal and neonatal drugs can provide important diagnostic clues. Presence of bleeding with or without petechiae and ecchymoses in a healthy term or late preterm infant with thrombocytopenia but normal prothrombin time and activated partial thromboplastin time strongly suggests a congenital bleeding disorder. For a sick infant who is bleeding from multiple sites, an acquired disorder such as disseminated intravascular coagulation is suspected. Intracranial hemorrhage in term or late preterm infants without a history of birth trauma is highly suggestive of coagulation disorders. The purpose of this review is to summarize recent advances in diagnostic methods is as well as basic concepts of neonatal hemostatic disorders. First, an outline of background information will be presented followed by a discussion of primary and secondary hemostatic disorders as well as inherited and acquired disorders.

신생아 출혈은 신생아실에서 흔하게 경험하는 증상 중 하나이며 신생아중환자실에서는 특히 미숙아에게 종종 발생하므로 신속한 진단 및 즉각적인 치료가 필수적이다. 신생아 출혈은 이환율과 사망률의 중요한 원인이 되며 심한 경우 생명을 위협할 수 있다. 특히 최근 들어 비약적인 신생아학의 발달로 인해 초극소저체중출생아를 포함한 미숙아들의 생존율이 높아지고 있어 혈액응고질환의 진단 및 치료의 중요성은 날로 높아져 간다고 하겠다. 출혈이 의심되는 신생아의 정확한 진단을 위해서는 출혈의 가족력, 산모의 병력, 과거 임신력, 신생아 및 산모의 약물복용여부를 포함한 자세한 병력청취가 무엇보다 주의 깊게 시행되어야 하고 특정부위에 국한되어 증상을 보이는지 아니면 광범위한 출혈인지 감별을 해야 한다. 혈소판감소증만 단독으로 보이는 신생아의 경우 자반증(petechiae)과 반상출혈(ecchymoses), 점막출혈 등이 동반될 수 있으나 대부분은 건강해 보이며 비타민 K 결핍출혈, 혈우병 같은 선천성 응고장애를 의심해 볼 수 있으며, 아파 보이는 신생아에서 폐, 위장관, 비뇨생식기계, 천자부위 등에서 출혈이 일어나는 경우는 파종성 혈관내응고증후군을 포함한 후천성 응고이상을 의심해 볼 수 있다. 특별히 외상의 흔적이나 난산의 병력이 없는 만삭아나 준미숙아 등에서 두개 내 출혈이 보이는 경우에도 반드시 혈액응고이상 질환을 의심해봐야 한다. 저자는 본 종설을 통해 신생아출혈을 유발하는 혈액응고질환에 대해 임상유형 및 발생기전에 따라 대해 1차성 및 2차성 응고이상질환으로 나누어 알아보고 이를 다시 선천성 응고장애질환과 후천성 응고장애질환으로 나눠 각각에 대해 최신지견을 토대로 자세히 살펴보고자 한다.

Keywords

References

  1. Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004;89:F475-8. https://doi.org/10.1136/adc.2004.050096
  2. Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009;33: 52-65. https://doi.org/10.1053/j.semperi.2008.10.007
  3. Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003;88:F359-64. https://doi.org/10.1136/fn.88.5.F359
  4. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104. https://doi.org/10.1097/00043426-199021000-00019
  5. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
  6. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7.
  7. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-6.
  8. Kenet G, Chan AK, Soucie JM, Kulkarni R. Bleeding disorders in neonates. Haemophilia 2010;16 Suppl 5:168-75.
  9. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363-6.
  10. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-55. https://doi.org/10.1111/j.1479-828X.2001.tb01293.x
  11. Bussel JB, Sola-Visner M. Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 2009;33:35-42. https://doi.org/10.1053/j.semperi.2008.10.003
  12. Kuhle S, Mitchell L, Massicotte P, Andrew M. Hemostatic disorders of the newborn. In: Taeusch HW, Ballard RA, Gleason CA, editors. Avery's diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders, 2005:1145-79.
  13. Choi JS, Kim SY, Ihm C, Kim SY. A case of neonatal alloimmune thrombocytopenia due to anti-HLA-B35. J Korean Soc Neonatol 2009;16:248-54.
  14. Murphy MF, Bussel JB. Advances in the management of alloimmune thrombocytopenia. Br J Haematol 2007;136:366-78. https://doi.org/10.1111/j.1365-2141.2006.06418.x
  15. Bussel J. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009;7 Suppl 1:253-7.
  16. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-6. https://doi.org/10.1056/NEJM199311113292005
  17. Bussel JB, McFarland JG, Berkowitz RL. Antenatal management of fetal alloimmune and autoimmune thrombocytopenia. Transfus Med Rev 1990;4:149-62. https://doi.org/10.1016/S0887-7963(90)70260-X
  18. Baehner RL, Strauss HS. Hemophilia in the first year of life. N Engl J Med 1966;275:524-8. https://doi.org/10.1056/NEJM196609082751003
  19. Ljung RC. Prenatal diagnosis of haemophilia. Haemophilia 1999;5:84-7. https://doi.org/10.1046/j.1365-2516.1999.00295.x
  20. Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia. Br J Haematol 2001;112:264-74. https://doi.org/10.1046/j.1365-2141.2001.02362.x
  21. Cox Gill J. Diagnosis and treatment of von Willebrand disease. Hematol Oncol Clin North Am 2004;18:1277-99. https://doi.org/10.1016/j.hoc.2004.07.006
  22. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994;71:520-5.
  23. Gazengel C, Fischer AM, Schlegel N, Rothschild C, Torchet MF, Dautzenberg MD, et al. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates. Nouv Rev Fr Hematol 1988;30:225-7.
  24. Nichols WC, Ginsburg D. von Willebrand disease. Medicine (Baltimore) 1997;76:1-20. https://doi.org/10.1097/00005792-199701000-00001
  25. Rha JY, Kook JH, Kook H, Yang SJ, Cho D, Ryang DW, et al. Three cases of factor XI deficiency. Korean J Pediatr Hematol Oncol 2001; 8:344-8.
  26. Kim HJ, Jung JH, Lee JH, Jo JD. A case of congenital factor VII deficiency associated with intraventricular hemorrhage and hydrocephalus. J Korean Pediatr Soc 1998;41:1726-30.
  27. Cho KC, Lee SK, Kim IK, Sung H, Choi CH. A case of combined congenital deficiency of factor V and factor VIII. J Korean Pediatr Soc 1996;39:1162-7.
  28. Townsend CW. The haemorrhagic disease of the newborn. Arch Pediatr 1894;11:559-65.
  29. McNinch A. Vitamin K deficiency bleeding: early history and recent trends in the United Kingdom. Early Hum Dev 2010;86 Suppl 1:63- 5.
  30. Sutor AH, von Kries R, Cornelissen EA, McNinch AW, Andrew M. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/ Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 1999;81:456-61.
  31. Van Winckel M, De Bruyne R, Van De Velde S, Van Biervliet S. Vitamin K, an update for the paediatrician. Eur J Pediatr 2009;168: 127-34. https://doi.org/10.1007/s00431-008-0856-1
  32. American Academy of Pediatrics, Committee on Nutrition. Pediatric nutrition handbook. 6th ed. Elk Grove Village: American Academy of Pediatrics, 2009:468-71.
  33. Shapiro AD, Jacobson LJ, Armon ME, Manco-Johnson MJ, Hulac P, Lane PA, et al. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J Pediatr 1986;109:675-80. https://doi.org/10.1016/S0022-3476(86)80241-4
  34. von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of Scientific and Standardization, Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993;69:293-5.
  35. Clark FI, James EJ. Twenty-seven years of experience with oral vitamin K1 therapy in neonates. J Pediatr 1995;127:301-4. https://doi.org/10.1016/S0022-3476(95)70315-2
  36. Vietti TJ, Murphy T, James JA, Pritchard JA. Observation on the prophylactic use of vitamin K in the newborn. J Pediatr 1960;56: 343-6. https://doi.org/10.1016/S0022-3476(60)80185-0
  37. Cornelissen EA, Kollee LA, De Abreu RA, Motohara K, Monnens LA. Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr 1993;82:656-99.
  38. Schubiger G, Stocker C, Bänziger O, Laubscher B, Zimmermann H. Oral vitamin K1 prophylaxis for newborns with a new mixedmicellar preparation of phylloquinone: 3 years experience in Switzerland. Eur J Pediatr 1999;158:599-602. https://doi.org/10.1007/s004310051155
  39. Lippi G, Franchini M. Vitamin K in neonates: facts and myths. Blood Transfus 2011;9:4-9.
  40. Bick RL. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 2002;8:1-31. https://doi.org/10.1177/107602960200800103
  41. Veldman A, Fischer D, Nold MF, Wong FY. Disseminated intravascular coagulation in term and preterm neonates. Semin Thromb Hemost 2010;36:419-28. https://doi.org/10.1055/s-0030-1254050
  42. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92. https://doi.org/10.1056/NEJM199908193410807
  43. Kreuz W, Veldmann A, Fischer D, Schlosser R, Volk WR, Ettingshausen CE. Neonatal sepsis: a challenge in hemostaseology. Semin Thromb Hemost 1999;25:531-5. https://doi.org/10.1055/s-2007-994961
  44. von Kries R, Stannigel H, Göbel U. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. Eur J Pediatr 1985;144:191-4. https://doi.org/10.1007/BF00451912
  45. Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:470-6. https://doi.org/10.1164/ajrccm.158.2.9712116
  46. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993;104:882-8. https://doi.org/10.1378/chest.104.3.882
  47. Newall F, Johnston L, Ignjatovic V, Monagle P. Unfractionated heparin therapy in infants and children. Pediatrics 2009;123:e510-8. https://doi.org/10.1542/peds.2008-2052
  48. Martchenke J, Boshkov L. Heparin-induced thrombocytopenia in neonates. Neonatal Netw 2005;24:33-7.
  49. Risch L, Huber AR, Schmugge M. Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 2006;118:123-35. https://doi.org/10.1016/j.thromres.2004.12.020

Cited by

  1. Causes and Neonatal Outcome of Early-Onset Thrombocytopenia in Preterm Neonates vol.22, pp.3, 2011, https://doi.org/10.5385/nm.2015.22.3.156